Retour
Fourchette du Jour
13,20 €
13,70 €
Fourchette 52 Semaines
3,11 €
17,49 €
Volume
896 797
Moyenne 50J / 200J
14,34 €
/
11,68 €
Clôture Précédente
13,53 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,9 | 0,4 |
| P/B | 3,7 | 2,9 |
| ROE % | -61,6 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
22,00 €
+61.1%
Low: 19,00 €
High: 28,00 €
BPA Prévisionnel
-1,35 €
CA Est.
81000
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,07 €
0,44 € – 3,76 €
|
540 M | 2 |
| FY2029 |
0,69 €
0,15 € – 1,26 €
|
320 M | 4 |
| FY2028 |
-0,57 €
-1,04 € – 0,23 €
|
150 M | 6 |
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -123,48M
PEG of 0,12 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-61,59%
ROIC-36,94%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio14,27
Interest Coverage0,00
Valorisation
P/E Ratio
-7,85
P/B Ratio3,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -144,74M |
| ROE | -61,59% | ROA | -43,51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -123,48M |
| ROIC | -36,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 14,27 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,85 | P/B Ratio | 3,72 |
| P/S Ratio | N/A | PEG Ratio | 0,12 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,14B | Enterprise Value | 914,79M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 87,37M | 380,79M | 22,23M | 0,0 |
| Net Income | -144,74M | -301,74M | 49,27M | -198,38M | -87,93M |
| EPS (Diluted) | -1,53 | -4,43 | 0,70 | -2,98 | -1,52 |
| Gross Profit | -525 000,0 | 45,22M | 355,35M | 19,24M | 0,0 |
| Operating Income | -153,29M | -314,73M | 38,80M | -201,34M | -82,69M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 332,65M | 193,63M | 517,45M | 391,45M | 105,61M |
| Total Liabilities | 27,39M | 28,87M | 84,02M | 50,85M | 256,78M |
| Shareholders' Equity | 305,26M | 164,77M | 433,43M | 340,61M | -151,17M |
| Total Debt | 5,96M | 1,98M | 4,24M | 6,28M | 0,0 |
| Cash & Equivalents | 226,65M | 77,39M | 170,20M | 62,53M | 50,19M |
| Current Assets | 323,67M | 189,43M | 464,67M | 382,13M | 104,95M |
| Current Liabilities | 22,69M | 28,41M | 82,04M | 46,61M | 17,40M |